PSA Screening Debate, Brain Metastases in HER2 Positive Breast Cancer, and Subcutaneous Immunotherapy
Curie: The Oncology Brief di Curie: The Platform for HCPs
Note sull'episodio
Love what you hear? Download the Curie app from the App Store today.
Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals.
In this episode of Curie, Matt breaks down three critical updates in oncology. A new study links declining PSA screening rates to a rise in advanced prostate cancer cases, raising questions about early detection guidelines. We then explore new findings on brain metastases in HER2 positive breast cancer, revealing how patients with CNS only disease have significantly better outcomes ...
Parole chiave
OncologypodcastTreatmentimmunotherapyBreast cancerHCPsDoctorsUSAprostate cancerhematologyHER2 positive breast cancerFDA